<DOC>
	<DOCNO>NCT00408785</DOCNO>
	<brief_summary>This Multicenter , double-blind , randomize , placebo-controlled , parallel-group comparative study confirm efficacy safety BOTOX 20 unit single injection Chinese patient glabellar line . The subject receive single intramuscular treatment consist 5 injection either BOTOX ? 20U placebo .</brief_summary>
	<brief_title>A Study Of BOTOX For The Treatment Of Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Inclusion criterion : Male female adult Glabellar line least moderate severity maximum frown investigator 's assessment . Exclusion criterion : Patients systemic nerve conduction junction disorder patient infection skin disease/surgery injection sit eligible . Patient severe complication related heart , kidney , liver disease respiratory system eligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>glabellar line</keyword>
</DOC>